Jaguar Gene Therapy focuses on accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, according to their self-described mission.

Jaguar Gene Therapy

IPhone / Mobile Compatible

Viewport Meta

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Content Delivery Network

WordPress

Global Site Tag

Organization Schema

Chief Operating Officer

Andrew Knudten

Chief Medical Officer

Joe Mcintosh

Legal

Michael Johannesen

Chief Financial Officer

Phillip Donenberg

President, R&D and Chief Medical Officer

Sukumar Nagendran

VP of Engineering

Bryan Grice

Vice President, Medical Affairs

Daniel Gallo

Vice President - Preclinical Programs

Daniel McCoy

Vice President, Process Sciences

Gretchen Smith

Vice President Process Science

Joe Balleydier

David Greenwald

Joseph McIntosh

Joseph Nolan

President and Chief Executive Officer

Michael B. Johannesen

Chief Legal Officer

President of R&D

Great Lakes Companies With More Than 10 Employees (Top 10K)

Eli Lilly Portfolio Companies

Greater Chicago Area Companies (Top 10K)

Great Lakes Companies With Fewer Than 50 Employees (Top 10K)

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

JDRF T1D Fund

Samsung Ventures

Venture Round - Jaguar Gene Therapy

Deerfield

Eli Lilly

Series B - Jaguar Gene Therapy

Series A - Jaguar Gene Therapy

Computer and Software Services and Scientific Services

Lake Forest

Illinois

United States

North America

Lake Forest biotech set to test genetic therapy in young autistic patients

Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial Targeting a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome

Advanced Medicine Partners Executes Additional $32 Million Financing Agreement led by Deerfield Management ...

Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum ...

New contract manufacturer to be spun out of Jaguar Gene Therapy

Jaguar Gene Therapy spins off Advanced Medicine Partners

Gene therapy biotech Jaguar spins out manufacturing company

A gene therapy in preclinical development aimed at treating Type 1 galactosemia by delivering the functional GALT gene using an AAV9 vector.

An investigational gene therapy targeting disorders resulting from SHANK3 mutation or deletion, including autism spectrum disorder and Phelan-McDermid syndrome.

A preclinical AAV-based gene therapy designed to address the root cause of Type 1 diabetes by producing functional beta cells through transdifferentiation.

Palestinian Territory

Asia

Canada

India

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 2, 2024 12:54 PM	eb049a5f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 2, 2024 12:54 PM	d8bf642b
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b002b827
crunchbase profile	general	Nov 27, 2024 1:24 PM	fe65c395
li profile	general
translate crunchbase fundingrounds	general	Nov 27, 2024 2:00 PM	f3b9a57c
peers	general	Oct 2, 2024 12:54 PM	a619c3a9
news basic	general	Oct 2, 2024 12:54 PM	e997dda0
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:JAGUARGENETHERAPY

Jaguar Gene Therapy